Treatment of Bronchitis: Bacterial vs. Viral
Acute bronchitis is predominantly viral in origin (>90% of cases) and does not require antibiotic therapy, while chronic bronchitis exacerbations may benefit from antibiotics only when specific criteria are met.
Acute Bronchitis
Diagnosis and Etiology
- Acute bronchitis is characterized by cough lasting up to 3 weeks, with or without sputum production 1
- Over 90% of acute bronchitis cases have a nonbacterial cause, primarily viral infections 2
- Common viral causes include:
- Influenza A and B
- Parainfluenza virus
- Respiratory syncytial virus (RSV)
- Coronavirus
- Adenovirus
- Rhinovirus 2
- Only a small percentage (5-10%) of cases are caused by bacterial pathogens such as:
- Bordetella pertussis
- Mycoplasma pneumoniae
- Chlamydia pneumoniae 2
Treatment Recommendations
No routine antibiotics for acute bronchitis 1, 2
- Antibiotics do not significantly improve outcomes
- May only decrease cough duration by approximately 0.5 days 3
- Expose patients to unnecessary adverse effects
Specific exceptions for antibiotic use:
- Suspected or confirmed pertussis (macrolides such as erythromycin)
- Patients with underlying pulmonary disease at high risk for complications 1
Symptomatic management:
Chronic Bronchitis
Diagnosis and Classification
- Defined as daily productive cough for at least 3 consecutive months, present for at least 2 consecutive years 1
- Classified into three stages:
Treatment of Stable Chronic Bronchitis
- Smoking cessation - most effective intervention, resolves cough in 90% of patients 1
- Avoidance of respiratory irritants 1
- Symptomatic management:
- Short-acting β-agonists
- Ipratropium bromide
- Long-acting β-agonist with inhaled corticosteroids (ICS)
- ICS therapy 1
Treatment of Acute Exacerbations of Chronic Bronchitis
When to Use Antibiotics
Antibiotic therapy is recommended when:
For simple chronic bronchitis:
- Only if fever (>38°C) persists for more than 3 days 2
For obstructive chronic bronchitis:
For obstructive chronic bronchitis with respiratory insufficiency:
- Immediate antibiotic therapy is recommended 2
Antibiotic Selection
First-line antibiotics (for infrequent exacerbations, FEV₁ ≥35%):
- Amoxicillin (reference compound)
- First-generation cephalosporins
- Macrolides, pristinamycin, or doxycycline (if allergic to beta-lactams) 2
Second-line antibiotics (for frequent exacerbations or FEV₁ <35%):
Common Pitfalls and Considerations
Misdiagnosis:
Antibiotic overuse:
- 65-80% of acute bronchitis patients receive antibiotics despite evidence against routine use 1
- Contributes to antibiotic resistance
Ineffective treatments:
Patient education:
- Inform patients about typical cough duration (2-3 weeks)
- Explain the viral nature of most cases
- Discuss risks of unnecessary antibiotic use 1
By following these evidence-based guidelines, clinicians can provide appropriate care for patients with bronchitis while avoiding unnecessary antibiotic use and its associated risks.